BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27899186)

  • 21. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
    Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
    Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial pancreatic cancer syndromes.
    Habbe N; Langer P; Sina-Frey M; Bartsch DK
    Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fanconi anemia gene mutations in young-onset pancreatic cancer.
    van der Heijden MS; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 May; 63(10):2585-8. PubMed ID: 12750283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
    Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
    Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indication for CDKN2A-mutation analysis in familial pancreatic cancer families without melanomas.
    Harinck F; Kluijt I; van der Stoep N; Oldenburg RA; Wagner A; Aalfs CM; Sijmons RH; Poley JW; Kuipers EJ; Fockens P; van Os TA; Bruno MJ
    J Med Genet; 2012 Jun; 49(6):362-5. PubMed ID: 22636603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
    Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
    Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
    Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
    Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
    Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial pancreatic cancer.
    Hruban RH; Petersen GM; Goggins M; Tersmette AC; Offerhaus GJ; Falatko F; Yeo CJ; Kern SE
    Ann Oncol; 1999; 10 Suppl 4():69-73. PubMed ID: 10436789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial pancreatic cancer.
    Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
    Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predisposition to pancreatic cancer.
    Ghiorzo P
    World J Gastroenterol; 2014 Aug; 20(31):10778-89. PubMed ID: 25152581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Familial pancreatic cancer: Concept, management and issues.
    Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T
    World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic carcinoma surveillance in patients with familial melanoma.
    Parker JF; Florell SR; Alexander A; DiSario JA; Shami PJ; Leachman SA
    Arch Dermatol; 2003 Aug; 139(8):1019-25. PubMed ID: 12925390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the gene coding for the BRCA2-interacting protein PALB2 in familial and sporadic pancreatic cancer.
    Tischkowitz MD; Sabbaghian N; Hamel N; Borgida A; Rosner C; Taherian N; Srivastava A; Holter S; Rothenmund H; Ghadirian P; Foulkes WD; Gallinger S
    Gastroenterology; 2009 Sep; 137(3):1183-6. PubMed ID: 19635604
    [No Abstract]   [Full Text] [Related]  

  • 36. Familial pancreatic adenocarcinoma: A retrospective analysis of germline genetic testing in a French multicentre cohort.
    Schwartz M; Korenbaum C; Benfoda M; Mary M; Colas C; Coulet F; Parrin M; Jonveaux P; Ingster O; Granier S; De Mestier L; Cros J; Riffault A; Muller M; Levy P; Rebours V; Greenhalf W; Soufir N; Hammel P
    Clin Genet; 2019 Dec; 96(6):579-584. PubMed ID: 31432501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.
    Grant RC; Al-Sukhni W; Borgida AE; Holter S; Kanji ZS; McPherson T; Whelan E; Serra S; Trinh QM; Peltekova V; Stein LD; McPherson JD; Gallinger S
    Hum Genomics; 2013 Apr; 7(1):11. PubMed ID: 23561644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Familial pancreatic cancer--status quo.
    Fendrich V; Langer P; Bartsch DK
    Int J Colorectal Dis; 2014 Feb; 29(2):139-45. PubMed ID: 23948969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
    Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
    Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of BRCA2 mutations in familial pancreatic cancer.
    Couch FJ; Johnson MR; Rabe KG; Brune K; de Andrade M; Goggins M; Rothenmund H; Gallinger S; Klein A; Petersen GM; Hruban RH
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):342-6. PubMed ID: 17301269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.